Document is current
Any future updates will be listed below
-
Authors
Xiong, Wenyuan
Papasouliotis, Orestis
Jonsson, E. Niclas
Strotmann, Rainer
Girard, Pascal https://orcid.org/0000-0002-8522-3718
-
Funding
Funding for this research was provided by:
Merck KGaA
- License Information
-
More Information
Article History
Received: 29 November 2021
Accepted: 14 March 2022
First Online: 6 April 2022
Declarations
:
: Wenyuan Xiong was employed by the Merck Institute of Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA for the duration of the study. Orestis Papasouliotis and Pascal Girard are employees of the Merck Institute of Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA. Rainer Strotmann is an employee of Merck Healthcare KGaA, Darmstadt, Germany. E. Niclas Jonsson is an employee of Pharmetheus AB, Sweden.
: All studies were approved by appropriate ethics committees and were conducted in accordance with the principles of the Declaration of Helsinki and the International Council on Harmonisation Good Clinical Practice guidelines.
: Written informed consent was obtained from all participants before any study-related procedures were performed.
: All authors consented to the publication of this article.
